ReviewClinical ophthalmology (Auckland, N.Z.)2015
Implantable inlay devices for presbyopia: the evidence to date.
Review in Clinical ophthalmology (Auckland, N.Z.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Small-aperture intracorneal inlay implantation in emmetropic presbyopic patients: a systematic review.Eye (London, England) · 2022Pooled it
- Current Trends in Presbyopia Correction-A Comprehensive Review.Journal of clinical medicine · 2025Review
- The Preservation and Reuse of Lenticules Extracted via Small Incision Lenticule Extraction (SMILE): A Narrative Review.Bioengineering (Basel, Switzerland) · 2025Review
- Effects of Miosis on the Visual Acuity Space under Varying Conditions of Contrast and Ambient Luminance in Presbyopia.Journal of clinical medicine · 2024Article
- Applications of SMILE-extracted lenticules in ophthalmology.International journal of ophthalmology · 2024Review
- IRISClinical ophthalmology (Auckland, N.Z.) · 2023Article
- Refractive surgery beyond 2020.Eye (London, England) · 2021Review
- Spectacle Independence for Pseudophakic Patients - Experience with a Trifocal Supplementary Add-on Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2020Article
- Correction of hyperopia by intrastromal cutting and liquid filler injection.Journal of biomedical optics · 2019Article
- Biological corneal inlay for presbyopia derived from small incision lenticule extraction (SMILE).Scientific reports · 2018Article
- Long-term changes in keratometry and refraction after small aperture corneal inlay implantation.Clinical ophthalmology (Auckland, N.Z.) · 2018Article
- A Review of Presbyopia Treatment with Corneal Inlays.Ophthalmology and therapy · 2017Review
- Comparison of a hydrogel corneal inlay and monovision laser in situ keratomileusis in presbyopic patients: focus on visual performance and optical quality.Clinical ophthalmology (Auckland, N.Z.) · 2017Article
- Comparison of FDA safety and efficacy data for KAMRA and Raindrop corneal inlays.International journal of ophthalmology · 2017Article
- Clinical utility of the KAMRA corneal inlay.Clinical ophthalmology (Auckland, N.Z.) · 2016Review
- Cataract Surgery with a Refractive Corneal Inlay in Place.Case reports in ophthalmological medicine · 2015Article
- Review of Static Approaches to Surgical Correction of Presbyopia.Journal of ophthalmic & vision researchReview
- Correction of presbyopia: An integrated update for the practical surgeon.Taiwan journal of ophthalmologyReview
- KAMRA Inlay Implantation for Presbyopia Compensation: A Retrospective Evaluation of Patient Satisfaction and Subjective Vision 12-Month Postoperative.Middle East African journal of ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
By 2020, it is estimated that 2.1 billion people will be presbyopic, and the demand for spectacle independence in this group is growing. This review article provides an overview of the three commercially available corneal inlays for the correction of presbyopia. Safety, efficacy, visual outcomes, and complications are analyzed for all three inlays according to published peer-reviewed data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.